Biotika a.s. (BSSE:1BSL01AE)
Slovakia · Delayed Price · Currency is EUR 10.80
0.00 (0.00%)
At close: Jun 12, 2026
Biotika a.s. Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 17.53 | 16.76 | 22.07 | 11.03 | 8.91 |
Other Revenue | 0.62 | 0.48 | 1.06 | - | - |
| 18.15 | 17.24 | 23.13 | 11.03 | 8.91 | |
Revenue Growth (YoY) | 5.30% | -25.46% | 109.66% | 23.83% | -49.53% |
Cost of Revenue | 14.02 | 12.15 | 15.3 | 8.52 | 16.09 |
Gross Profit | 4.13 | 5.09 | 7.82 | 2.51 | -7.19 |
Selling, General & Admin | 5.47 | 6 | 5.65 | 4.78 | 0.02 |
Other Operating Expenses | 0.81 | 0.74 | 0.62 | -2.76 | -7.67 |
Operating Expenses | 7.74 | 8.58 | 7.77 | 3.54 | -7.66 |
Operating Income | -3.61 | -3.49 | 0.06 | -1.04 | 0.47 |
Interest Expense | -0.1 | -0 | - | -0 | - |
Interest & Investment Income | - | - | - | 0.26 | 0.04 |
Currency Exchange Gain (Loss) | 0.01 | 0.01 | -0.01 | -0.02 | - |
Other Non Operating Income (Expenses) | - | - | - | -0.01 | - |
EBT Excluding Unusual Items | -3.7 | -3.48 | 0.04 | -0.8 | 0.51 |
Gain (Loss) on Sale of Investments | 0.2 | 0.51 | 0.08 | - | - |
Gain (Loss) on Sale of Assets | 2.31 | 0.15 | 0.1 | - | - |
Asset Writedown | - | - | - | -0.04 | - |
Pretax Income | -1.19 | -2.83 | 0.22 | -0.84 | 0.51 |
Income Tax Expense | 0 | -0.44 | -0.15 | -0.02 | 0.11 |
Net Income | -1.19 | -2.39 | 0.37 | -0.82 | 0.41 |
Net Income to Common | -1.19 | -2.39 | 0.37 | -0.82 | 0.41 |
Net Income Growth | - | - | - | - | -82.17% |
Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 1 |
Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 1 |
EPS (Basic) | -1.70 | -3.41 | 0.53 | -1.17 | 0.58 |
EPS (Diluted) | -1.70 | -3.41 | 0.53 | -1.17 | 0.58 |
Free Cash Flow | -0.78 | -2.56 | 0.65 | -0.08 | 0.04 |
Free Cash Flow Per Share | -1.12 | -3.66 | 0.93 | -0.12 | 0.06 |
Dividend Per Share | - | - | - | - | 0.500 |
Dividend Growth | - | - | - | - | -80.77% |
Gross Margin | 22.76% | 29.52% | 33.83% | 22.73% | -80.67% |
Operating Margin | -19.87% | -20.26% | 0.24% | -9.40% | 5.29% |
Profit Margin | -6.55% | -13.86% | 1.60% | -7.43% | 4.55% |
Free Cash Flow Margin | -4.32% | -14.86% | 2.81% | -0.73% | 0.44% |
EBITDA | -2.31 | -1.95 | 1.36 | 0.28 | 1.86 |
EBITDA Margin | -12.74% | -11.28% | 5.89% | 2.50% | 20.87% |
D&A For EBITDA | 1.29 | 1.55 | 1.31 | 1.31 | 1.39 |
EBIT | -3.61 | -3.49 | 0.06 | -1.04 | 0.47 |
EBIT Margin | -19.87% | -20.26% | 0.24% | -9.40% | 5.29% |
Effective Tax Rate | - | - | - | - | 21.17% |
Revenue as Reported | 13.05 | 12.15 | 16.18 | 14.29 | 16.58 |